LRRK2 and Parkinson disease: Other authors have reported heightened autophagic flux and higher expression of autophagy markers as well as an increased mitophagy in G2019S-LRRK2-mutation carriers with clinical diagnosed PD (Smith et al., 2015; Su et al., 2015).